Potent antibody therapeutics by design


Antibodies constitute the most rapidly growing class of human therapeutics and the second largest class of drugs after vaccines. The generation of potent antibody therapeutics, which I review here, is an iterative design process that involves the generation and optimization of antibodies to improve their clinical potential.

DOI: 10.1038/nri1837
Citations per Year

4,624 Citations

Semantic Scholar estimates that this publication has 4,624 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Carter2006PotentAT, title={Potent antibody therapeutics by design}, author={Paul J. Carter}, journal={Nature Reviews Immunology}, year={2006}, volume={6}, pages={343-357} }